HomeCompareTCPC vs SYK

TCPC vs SYK: Dividend Comparison 2026

TCPC yields 28.25% · SYK yields 1.04%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 TCPC wins by $5.7K in total portfolio value
10 years
TCPC
TCPC
● Live price
28.25%
Share price
$3.54
Annual div
$1.00
5Y div CAGR
-15.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.0K
Annual income
$1,317.64
Full TCPC calculator →
SYK
SYK
● Live price
1.04%
Share price
$326.10
Annual div
$3.40
5Y div CAGR
46.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$43.3K
Annual income
$8,282.98
Full SYK calculator →

Portfolio growth — TCPC vs SYK

📍 TCPC pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTCPCSYK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, TCPC + SYK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
TCPC pays
SYK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

TCPC
Annual income on $10K today (after 15% tax)
$2,401.13/yr
After 10yr DRIP, annual income (after tax)
$1,119.99/yr
SYK
Annual income on $10K today (after 15% tax)
$88.62/yr
After 10yr DRIP, annual income (after tax)
$7,040.53/yr
At 15% tax rate, SYK beats the other by $5,920.54/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of TCPC + SYK for your $10,000?

TCPC: 50%SYK: 50%
100% SYK50/50100% TCPC
Portfolio after 10yr
$46.2K
Annual income
$4,800.31/yr
Blended yield
10.40%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on SYK right now

TCPC
Analyst Ratings
4
Buy
7
Hold
2
Sell
Consensus: Hold
Price Target
$8.00
+126.0% upside vs current
Range: $8.00 — $8.00
Altman Z
-1.0
Piotroski
6/9
SYK
Analyst Ratings
1
Strong
35
Buy
14
Hold
Consensus: Buy
Price Target
$428.67
+31.5% upside vs current
Range: $390.00 — $469.00
Altman Z
4.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

TCPC buys
0
SYK buys
0
No recent congressional trades found for TCPC or SYK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTCPCSYK
Forward yield28.25%1.04%
Annual dividend / share$1.00$3.40
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-15.2%46.2%
Portfolio after 10y$49.0K$43.3K
Annual income after 10y$1,317.64$8,282.98
Total dividends collected$20.5K$21.0K
Payment frequencyquarterlyquarterly
SectorBDCHealthcare
Analyst consensusHoldBuy
Analyst price target$8.00$428.67

Year-by-year: TCPC vs SYK ($10,000, DRIP)

YearTCPC PortfolioTCPC Income/yrSYK PortfolioSYK Income/yrGap
1← crossover$13,095$2,395.48$10,852$152.43+$2.2KTCPC
2$16,498$2,486.14$11,838$226.03+$4.7KTCPC
3$20,135$2,482.31$13,004$336.89+$7.1KTCPC
4$23,946$2,400.99$14,420$505.63+$9.5KTCPC
5$27,885$2,262.94$16,195$766.09+$11.7KTCPC
6$31,926$2,088.46$18,504$1,175.64+$13.4KTCPC
7$36,055$1,894.98$21,635$1,835.40+$14.4KTCPC
8$40,275$1,696.08$26,082$2,932.10+$14.2KTCPC
9$44,596$1,501.51$32,737$4,829.68+$11.9KTCPC
10$49,035$1,317.64$43,312$8,282.98+$5.7KTCPC

TCPC vs SYK: Complete Analysis 2026

TCPCBDC

BlackRock TCP Capital Corp. is a business development company specializing in direct equity and debt investments in middle-market, debt securities, senior secured loans, junior loans, originated loans, mezzanine, senior debt instruments, bonds, and secondary-market investments. It typically invests in communication services, public relations services, television, wireless telecommunication services, apparel, textile mills, restaurants, retailing, energy, oil and gas extraction, Patent owners and Lessors, Federal and Federally- Sponsored Credit agencies, insurance, hospital and healthcare centers, Biotechnology, engineering services, heavy electrical equipment, tax accounting, scientific and related consulting services, charter freight air transportation, Information technology consulting, application hosting services, software diagram and design, computer aided design, communication equipment, electronics manufacturing equipment, computer components, chemicals. It seeks to invest in the United States. The fund typically invests between $10 million and $35 million in companies with enterprise values between $100 million and $1500 million including complex situations. It prefers to make equity investments in companies for an ownership stake.

Full TCPC Calculator →

SYKHealthcare

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.

Full SYK Calculator →
📬

Get this TCPC vs SYK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

TCPC vs SCHDTCPC vs JEPITCPC vs OTCPC vs KOTCPC vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.